CROI 2017 Program and Information

Program and Agenda

Durham, Phillip, G. Self: Employee of RTI International Eaton, Ellen, F. For self, paid to my institution: Research grant recipient from Other Bristol Myers Squibb Virology Fellowship Recipient, Analyst on Merck-funded project Eckard, Allison, R. Self: Consultant Gilead Sciences For self, paid to my institution: Research grant recipient from Bristol- Myers Squibb, Cubist Pharmaceuticals, and GlaxoSmithKline Eckhardt, Benjamin, Self: Research grant recipient from and consultant Gilead Sciences, Inc Ellis, Ronald, J. Spouse or Partner: Stockholder of Merck & Co, Inc, Abbott, and Johnson and Johnson Emu, Brinda Self: Consultant for Taimed and 3V Biosciences Erlandson, Kristine Self: Research grant recipient from and consultant for Gilead Sciences, Inc and Theratechnologies Esser, Stefan Self, For self, paid to my institution: Research grant recipient from Consultant Abbvie, BMS, Gilead, Merck & Co, Inc, Janssen, ViiV Evans, Ceri Self: Other for GlaxoSmithKline Fleisher, Ilan Self: Employee of MedStar Health Research Flexner, Charles, W. Self: Consultant for Merck & Co, Inc, Mylan, Inc, and ViiV Healthcare For self, paid to my institution: Research grant recipient from Gilead Sciences, Inc Frange, Pierre Self: Consultant for Merck & Co, Inc, ViiV Healthcare, Bristol-Myers Squibb, Janssen Therapeutics, and Gilead Sciences, Inc Gandhi, Rajesh, T. For self, paid to my institution: Grants from EBSCO Information Services, Gilead Sciences, Inc, Merck & Co, Inc, and ViiV Healthcare Gatell, Jose, M. Self: Consultant of Gilead Sciences, Inc, Merck & Co, Inc, ViiV Healthcare, and Janssen Therapeutics For self, paid to my institution: Research grant recipient from ViiV Healthcare, Merck & Co, Inc, Gilead Sciences, Inc, and Janssen Therapeutics Gaur, Aditya For self, paid to my institution: Research grant recipient from Gilead Sciences, Inc

Gerstenhaber, Rodd Self: Employee of Medecins Sans Frontieres Girardi, Enrico Self: Speaker’s bureau for Janssen Therapeutics, Gilead Sciences, Inc, Otsuka, and Angelini. Research grant recipient from Self: Gilead provides free study drug to project participants and covers the cost of some testing González-García, Juan Self: Consultant and speaker’s buerau for ViiV Healthcare, Gilead Sciences, Inc, Abbvie, and Merck Sharp Dohme For self, paid to my institution: Research grant from ViiV Healthcare, Gilead Sciences, Inc, Merck Sharp Dhome, Abbvie, Bristol-Myers Squibb, and Janssen-Cilag Gonzalez-Perez, Maria Paz Self: Employee of (company not indicated) Grattoni, Alessandro Self: Stockholder of NanoMedical Systems Grimwood, Ashraf Self: Employee of Kheth’Impilo Grinsztejn, Beatriz Self: Employee of Fundação Oswaldo Cruz Guaraldi, Giovanni Self: Consultant and speaker’s bureau for Gilead Sciences, Inc., Janssen Therapeutics, Bristol-Myers Squibb, GlaxoSmithKline. Grant recipient from ViiV Healthcareand Merck & Co, Inc Gupta, Ravindra, K. Self: Speaker’s bureau for Janssen Therapeutics Hagins, Debbie For self, paid to my institution: Research grant recipient from Gilead Sciences, Inc Hamzah, Lisa Self: Other from Gilead Sciences, Inc Hayes, Richard Self: Royalty holder from Chapman and Hall Hileman, Corrilynn, O. Self: Consultant for Gilead Sciences, Inc Hill, Andrew Self: Consultant for Merck & Co, Inc and Janssen Therapeutics Hillier, Sharon, L. Self: Consultant for Merck & Co, Inc, Cepheid, and Symbiomix, LLC Hodder, Sally Self: Consultant for Bristol-Myers Squibb, ViiV Healthcare, Gilead Sciences, Inc, and Janssen Therapeutics Spouse or Partner: Consultant for Sanofi, Novartis, and Johnson & Johnson Hogan, Michael, J. Self: Recipient of Intellectual Property Rights from University of Pennsylvania Gilead Sciences, Inc Golub, Sarit, A.

Disclosure Information

CROI 2017 218